GlassScriptPhysician profile
Terrence P Cescon
NPI 1841258696
$677.00
in general payments reported to CMS, 2019-2025
18 companies · $24.67 in 2025
The $24.67 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $319 · 2022: $199 · 2023: $135 · 2025: $24.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $135 · Food and Beverage: $24.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $135.12 |
| Food and Beverage | $24.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $318.52 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $99.99 | 2023 | Imbruvica |
| Incyte Corporation | $82.99 | 2022 | |
| Seagen INC. | $81.99 | 2022 | |
| Pfizer INC. | $47.53 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $30.66 | 2022-2023 | Keytruda |
| E.R. Squibb & Sons, L.L.C. | $15.32 | 2023 | Opdivo |
11 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Cescon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.